Stuart A. Williams

This profile gathers the share dealings of Stuart A. Williams in Mylan Laboratories Inc. The record holds 17 filings, for trades running from 5 January 2006 to 7 March 2008.

Both buying and selling appear: 4 purchases worth €294k, against 6 sales worth €5.1M. Netting one side against the other leaves €4.8M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant and 6 option exercises. Since January 2008: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €63k.

The newest entry dates from 10 March 2008: an open-market purchase of €69k, in Mylan Laboratories Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.